This was often associated with a variable amount of fibrosis of the soft tissues. With conventional X-ray therapy the maximum dose fell on the skin, which therefore suffered most severely.
The absorption of X-rays in tissue increases with increase in the atomic weights of the elements composing the tissues. Thus, absorption of X-rays in bone is two and a half times higher than in soft tissues, mainly due to the high calcium content of the skeleton.
-In clinical practice this had two disadvantages: firstly, in the irradiation of lesions deep to a bony structure, such as tumours of the mouth or maxillary antrum, the dose actually received by the tumour was materially less than the calculated dose, because the overlying bone acted as an absorbing shield; secondly, the very high dose received by the bone predisposed towards fracture in later years, and in the presence of infection, osteomyelitis and its complications.
The beam produced by an average 25o-kV.
X-ray therapy machine falls to 30 per cent. of its intensity by the time it has passed halfway through the body. It is thus very difficult to give a high dose of irradiation to deep-seated tumours, particularly where differential sensitivity between normal and malignant tissues is low. These difficulties have been largely overcome by the use of X-ray and gamma-ray beams generated at a voltage of one million or more, so-called supervoltage irradiation therapy.
With supervoltage rays the maximum dose falls not on the skin, but at a level 0.5 cm. deep to it for a i,ooo-curie 60Co source. The skin is thus comparatively spared. There are many types of supervoltage machine. In some powerful X-ray beams are produced by the impact of high-energy electrons on metallic targets; in others use is made of a penetrating beam of gamma rays produced by certain radioactive isotopes manufactured in the atomic pile.
One of this latter class of machine is the 'Theratron,' which combines the advantages of supervoltage irradiation with rotation of the treatment head. The 'Theratron' x,ooo-curie cobalt unit.
Two types of movement of the treatment head are possible: partial or complete rotation in the vertical plane and oscillation at right angles to it over a limited arc. Thus, whatever the position of the source, the central axis of the beam-as defined by diaphragms-passes through the same fixed point, which is the centre of rotation. Speed of rotation can be fixed at anything up to a maximum of two and a half revolutions per minute. The treatment couch has a full range of horizontal movements and vertical adjustments are hydraulically operated.
By means of these devices the centre of rotation can be made to coincide with any point within the body.
The output of the machine is about 45 r6ntgens per minute in air at 75 cm. from the source and treatment times vary between five and .15 minutes, depending on the depth of the lesion below the body surface. The radioactive cobalt source is approximately I,000 curies, which is equivalent to nearly 2,000 g. of radium element.
Advantages ofRotating Supervoltage Therapy
In addition to those -advantages of supervoltage treatment already mentioned, the use of partial or complete rotation of the treatment head gives the maximum possible ratio between the dose delivered to the tumour and the dose received by the surrounding normal tissues. During rotation the tumour is under continuous irradiation, whereas the normal tissues through which the beam is passing are constantly changing. Thus, normal tissues between skin surface and tumour receive a minimum dose and the risk of late radiation damage is therefore diminished.
The penetration of a supervoltage beam is so great that up to 25 per cent. of the beam may emerge on the other side of the patient. This high exit dose is a disadvantage; it is obviated by the use of a rotating head which ' distributes ' the total dose over a larger volume of tissue and consequently over a larger exit portal.
Radiation Dose
The biological effect of irradiation depends ultimately on physical and chemical changes taking place at the molecular level within the cell, or, looked at another way, on the number of ionizations occurring per unit volume of tissue.
Because the density of ionization per unit length of track increases as the energy of the beam increases, there were strong reasons for assuming that the dose of supervoltage irradiation in r6ntgens would have to be increased if biological effects comparable to those caused by 25o-kV. X-rays were to be achieved. This has proved to be so. 
Selection of Cases for Treatment
In the absence of past experience selection criteria had to be evolved empirically. It was decided that only those groups of cases which could not be effectively treated with conventional deep X-ray therapy would be considered for supervoltage irradiation, provided that the tumours were of types known to be radiosensitive in some degree.
In practice this meant that certain deep-seated tumours would be treated where an otherwise insufficient tumour dose would have been given with conventional X-rays. Carcinomas of the oesophagus, bronchus and bladder fell within this group. In addition, certain accessible tumours were treated where the violence of the mucosal reaction might have precluded the giving of a sufficient dose with 200-kV. X-rays. Carcinomas of the posterior part of the tongue, pharynx, postnasal space and extrinsic carcinomas of the larynx and post-cricoid region fell into this category.
The low absorption of supervoltage rays in bone commended their use in bone sarcomas and in soft tissue sarcomas adjacent, or fixed, to bone.
One group of cases chordomas was treated to test the accepted notions of tumour sensitivity.
Tumours of the Upper Air Passages
The site of origin of these tumours has been between the posterior one-third of the tongue and the upper trachea. The primary tumours have often been locally advanced and sometimes associated with fixed metastatic glandular masses when first seen.
It has been possible to treat most of these cases with one field, using a partial rotation technique.
Tumour resolution is often noted within three weeks of starting treatment and, in favourable cases, is well marked at the end of six weeks' irradiation.
In the minority who develop a brisk mucosal reaction it has been necessary to reduce the daily dose a little or sometimes to suspend treatment for a few days. The reaction usually subsides rapidly. Within a fortnight dysphagia improves and, in many cases, the patient may be eating solid food by the time of his discharge from hospital. The tumour can often be eradicated locally and a fibrotic stricture usually follows. These strictures need cautious dilatation later.
Most cases of carcinoma of the bladder have been fairly advanced when first seen. The volume of pelvic tissue to be treated is determined by examination under anaesthesia and cystoscopy with the insertion of markers. In nearly all cases it is necessary to treat the whole bladder with a full rotation technique. Symptomatic improvement is usual.
Chordomas
These tumours arise from the remnants of the primitive notochord. They have a characteristic histological picture with many small dark nuclei in large vacuolated cells. They may be found anywhere over the site of the notochord, but are most frequent in the sacral region.
Until recently chordomas were universally regarded as radio-resistant tumours and this belief, together with their surgical inaccessibility, made the outlook particularly poor.
Over 20 chordomas have been treated with dramatic results. The tumours are clearly radiosensitive and respond well to only moderate doses of supervoltage irradiation. Large masses filling the hollow of the sacrum have melted away and the disease has remained quiescent for observation periods of up to three years. Calcification of chordomas after irradiation is uncommon.
Sarcomas of Bone
A large group has been treated. Most sarcomas have limited radio-sensitivity and treatment policy has consisted in radical irradiation, followed by amputation in selected cases.
A tumour dose of 7,000 to 8,ooo r. has been delivered in about* seven weeks, often to large volumes of tissue without particular difficulty. The usual immediate result has been improvement in the patient's condition, disappearance of pain, marked regression in tumour size and recalcification of the area radiologically.
Subsequent management has depended on clinical and X-ray findings. If there is any clinical evidence of activity three to six months after irradiation and a chest X-ray is normal, amputation is advised; if there is no clinical evidence of activity, it is reasonable to postpone amputation.
The rationale for this policy is as follows: because of early blood-borne metastases amputation in bone sarcomas has given such generally bad results that it is being increasingly abandoned. By delaying operation-and using the interval for a radical radiotherapeutic attack on the tumournatural selection is allowed to act and those patients who develop pulmonary metastases are spared an unnecessary amputation.
Similar considerations apply to many soft tissue sarcomas.
Results
The follow-up period is too short for any permit the use of a Cobalt 60 source of small diameter to produce high dose rates.
THERATRON (Model B)
A larger source than the Theratron Junior (up to 2,000 curies) providing dose rates of 80 r per minute at sourceto-skin distances of 70 cm.
ELDORADO (Model G)
A high output unit for fixed beam or multiportal therapy. Provides dose rates of up to 100 r per minute at source-toskin distances from 50 to 150 cm.
